Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Short term Debt (2022 - 2025)

Rxo's Short term Debt history spans 4 years, with the latest figure at $17.0 million for Q4 2025.

  • For Q4 2025, Short term Debt changed 0.0% year-over-year to $17.0 million; the TTM value through Dec 2025 reached $17.0 million, changed 0.0%, while the annual FY2025 figure was $17.0 million, 0.0% changed from the prior year.
  • Short term Debt reached $17.0 million in Q4 2025 per RXO's latest filing, up from $16.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $17.0 million in Q4 2024 to a low of $3.0 million in Q3 2023.
  • Average Short term Debt over 4 years is $10.9 million, with a median of $15.5 million recorded in 2024.
  • Peak YoY movement for Short term Debt: plummeted 40.0% in 2023, then soared 466.67% in 2024.
  • A 4-year view of Short term Debt shows it stood at $4.0 million in 2022, then fell by 25.0% to $3.0 million in 2023, then skyrocketed by 466.67% to $17.0 million in 2024, then changed by 0.0% to $17.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Short term Debt are $17.0 million (Q4 2025), $16.0 million (Q3 2025), and $16.0 million (Q2 2025).